25 years of the WHO essential medicines lists: progress and challenges.
about
Better guidance is welcome, but without blindersMonitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran.Definition and Classification of Generic Drugs Across the WorldWorld Health Organization essential medicines lists: where are the drugs to treat neuropathic pain?Proposing Essential Medicines to Treat Cancer: Methodologies, Processes, and OutcomesAccessibility and use of essential medicines in health care: Current progress and challenges in IndiaQuantitative and qualitative analyses of the cell death process in Candida albicans treated by antifungal agentsA prescription for improving drug formulary decision makingToward a treaty on safety and cost-effectiveness of pharmaceuticals and medical devices: enhancing an endangered global public goodQuantitative evaluation of essential medicines lists: the South African case study.Transparent development of the WHO rapid advice guidelinesAccess to paediatric essential medicines: a survey of prices, availability, affordability and price components in Shaanxi Province, ChinaRational use effects of implementing an essential medicines list in West Bank, Palestinian Territories.Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces.A geospatial evaluation of timely access to surgical care in seven countries.In which developing countries are patents on essential medicines being filed?Cost-analysis of the WHO Essential Medicines List in A Resource-Limited Setting: Experience from A District Hospital in India.The evolution of Reference Drug Lists and Clinical Practice Guidelines in the public health system of a middle-income countryEffects of the National Essential Medicine System in reducing drug prices: an empirical study in four Chinese provinces.How phenobarbital revolutionized epilepsy therapy: the story of phenobarbital therapy in epilepsy in the last 100 years.Using the WHO essential medicines list to assess the appropriateness of insurance coverage decisions: a case study of the Croatian national medicine reimbursement list.National Essential Medicines List and policy practice: a case study of China's health care reformCardiovascular risk of NSAIDs: time to translate knowledge into practicePharmaceutical availability across levels of care: evidence from facility surveys in Ghana, Kenya, and Uganda.A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicinesA need for the standardization of the pharmaceutical sector in Libya.The availability of six tracer medicines in private medicine outlets in Uganda.Withdrawal-induced delirium associated with a benzodiazepine switch: a case report.Molecular dynamics simulations of large macromolecular complexes.Evaluation of the implementation outcomes of the Essential Medicines System in Anhui county-level public hospitals: a before-and-after study.Gaps in using bronchodilators, inhaled corticosteroids and influenza vaccine among 23 high- and low-income sites.Essential Medicines: An Indian Perspective.Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995-2015)Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members.Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff.Discounts and rebates granted to public payers for medicines in European countriesAn evaluation of the prescribing patterns for under-five patients at a Tertiary Paediatric Hospital in Sierra Leone.Developing clinical practice guidelines: target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest.Global pharmacogenetics: giving the genome to the masses.A retrospective audit of antibiotic prescriptions in primary health-care facilities in Eastern Region, Ghana.
P2860
Q21092316-2ED5FB63-834D-421F-82C5-9EE4CB082836Q24810348-CFF68F3B-C9A7-46B7-9A41-70BDD7C00E77Q26830753-31745D97-9E41-4F99-8071-7FD8819270B6Q27004578-40DF65E0-90E4-4414-9C0C-30837C23B49AQ28081319-9F3DA22B-443C-476E-887D-03117208B336Q28290409-078F5804-02AD-4706-95A7-F68C9F4E0C71Q28478335-F3AFEEBA-C157-4E2E-AF10-1D9623FF9C1FQ28483879-C5F813CF-2C03-4D89-B91D-9B66979F7B58Q28768386-08C347DE-BFCC-4E75-B4C1-75C8D2CC19F3Q30379852-83011D2A-C96F-482C-9EF5-8487FA4F00BAQ30444956-D3AC1976-548D-4EB9-A2C8-7E47610CAFD7Q31152459-C9D88D02-AFF5-4B79-84BD-C5F410B120C0Q33451782-BE7CAFC8-C99B-4935-B7D2-0A813ED72F5BQ33634671-50659E47-2F16-4AEE-90DF-C7C51893118AQ33777449-6483C02F-C792-48BD-872B-991BF09D6BDDQ33837177-6BDDA5F2-3DC0-4573-9059-DD45C0B9C147Q33839621-4221F6C6-AFEC-4297-8DA9-6D870A728F4BQ34065328-F20B924F-F437-491C-9D6D-1D660B1D782EQ34266928-9CF6F454-F8F7-4A22-BF91-2A5C92103682Q34315074-CD11FAC0-48B4-456C-A552-F323880284FDQ34388478-A9AAB7B3-F832-461A-8F7E-8C27871CA57EQ34476482-5373F51A-5FBE-4937-A713-667B9A9C614EQ34592497-D9D7525B-6ECB-4D84-9D76-C4817729AB79Q34681477-9659C236-46CB-4E7C-9215-96554E847DD6Q34736209-CC290E99-4052-4C20-B83E-6E15A7F329D0Q34736310-45139798-575B-4BA7-8083-3ACB0B418F69Q34769161-EC66B4F6-138C-497F-83A1-4B87207EDFF3Q35053076-C86EF535-5E6B-4931-BF43-F413B00A7033Q35768084-CA549402-414D-4FA8-8DEA-1331C3319C0AQ35783822-0B290CD8-18F4-47B3-A15A-900C403291E5Q35936008-DDEEDB39-4C4C-4167-96D9-4C0DAC9EF42EQ36088298-8E2B5E59-C8A1-4A8A-A474-462CC13E79F2Q36108573-D2F85B28-0700-4491-823B-21B42B0E004CQ36243403-C69C9388-17C4-4106-8AC6-5E6299243208Q36249454-61CF74C5-2F06-4506-9892-E61F16DCC8E2Q36317043-EA77873F-88E4-45F8-BDDE-A19E29EAE010Q36321083-C64939D4-3250-4EDF-801F-0934ECFC8E66Q36468650-DCE9B305-B34B-4E94-B88D-D6DD8ABCB367Q36497092-EEEAC48A-3559-4786-A83C-F8833F8B3E23Q36564755-BBE68059-AB45-4995-BDF2-26312606F5AF
P2860
25 years of the WHO essential medicines lists: progress and challenges.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
25 years of the WHO essential medicines lists: progress and challenges.
@ast
25 years of the WHO essential medicines lists: progress and challenges.
@en
25 years of the WHO essential medicines lists: progress and challenges.
@nl
type
label
25 years of the WHO essential medicines lists: progress and challenges.
@ast
25 years of the WHO essential medicines lists: progress and challenges.
@en
25 years of the WHO essential medicines lists: progress and challenges.
@nl
prefLabel
25 years of the WHO essential medicines lists: progress and challenges.
@ast
25 years of the WHO essential medicines lists: progress and challenges.
@en
25 years of the WHO essential medicines lists: progress and challenges.
@nl
P50
P1433
P1476
25 years of the WHO essential medicines lists: progress and challenges.
@en
P2093
Nathan Ford
Richard Laing
P304
P356
10.1016/S0140-6736(03)13375-2
P407
P577
2003-05-01T00:00:00Z